Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck CancersMISSISSAUGA, Ontario and HELSINKI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Microbix...
Cancer
Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025
FRIENDSWOOD, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1) Planning adaptive Phase...
TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
Highlights discovery of novel targets in T cell-driven autoimmune disorders; initial findings to be presented at the ACR Convergence 2025WALTHAM,...
Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis
Data support advancement of GS-6791 into clinical testing in patients with inflammatory diseases; first-in-human Phase 1 trial in healthy volunteers...
Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation
FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab...
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
PHOENIX, Ariz. and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company...
Amphista Therapeutics discloses first details of its SMARCA2 degrader program
Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite selectivity over close homolog, SMARCA4.Rapid,...
Deirdre Saulet, PhD, joins Jasper Health as Chief Strategy Officer
Brings Deep Expertise in Healthcare Strategy to Accelerate Jasper's Mission to Improve the Cancer Care Experience BOISE, Idaho, Sept. 16,...
Promising New Preclinical Therapy Offers Hope in the Development of Precision Medicine Treatments for Aggressive Cancers
Children's Hospital of Philadelphia Researchers Find New Therapies Show Promise Against ALK-Driven Cancers PHILADELPHIA, Sept. 16, 2025 /PRNewswire/ -- Researchers...
DeepScribe Solidifies Ambient AI Leadership in Oncology with New Study and Accelerated Growth
Study links DeepScribe to improved diagnosis capture and clinician experience, underscoring impact of product innovations and rapid growth in oncology...
Body Vision Medical Receives Regulatory Approval for LungVision® in India, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
WALTHAM, Mass., Sept. 16, 2025 /PRNewswire/ -- Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to...
Mobile Health Launches Breakthrough Engagement-Based Financial Model for Digital Health & Wellbeing
Eliminates PEPM Fees and Rewards Budgets — Helping Employers Save Hundreds of Thousands Annually While Delivering 24/7 "Care in Your...
Perimeter Medical Imaging AI Partners with Breast Cancer Patient Advocate Jennifer Douglas
Ms. Douglas to support patient engagement initiatives, joins Company's Industry Advisory Board TORONTO and DALLAS, Sept. 16, 2025 /PRNewswire/ -...
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS AGAIN NAMED ONE OF TOP HEALTH PLANS IN COUNTRY FOR QUALITY AND EXPERIENCE
PPO plan awarded 5 out of 5 stars by The National Committee for Quality Assurance BOSTON, Sept. 16, 2025 /PRNewswire/...
datma Unveils Federated Biomarker Explorer for Health Systems, Enabling Visibility Into Data Demand Without Data Sharing or Commitment
New offering gives health systems a way to determine whether their healthcare data aligns with pharmaceutical demand before engaging or...
Karmanos Cancer Institute’s BMT, Hematology and Multiple Myeloma Teams Welcome New Physician
Physician specializes in stem cell transplantation for blood cancers DETROIT, Sept. 16, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer...
As New Canadian Task Force on Preventive Health Care Takes Shape, Specialists Urge Prioritization of Early Detection and Expert Input
Ottawa, Ontario--(Newsfile Corp. - September 16, 2025) - When medical screening guidelines fail to prioritize early detection, they put Canadians...
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing...
The International Myeloma Foundation and IMF Nurse Leadership Board Inaugurate NLB Leadership and Mentorship Award
Honors IMF NLB Member Dr. Beth Faiman as First Recipient During the Inauguration and Awards CeremonyCLEVELAND, Ohio, Sept. 16, 2025...